Welsh, Carson’s Busy, Billion $$ Week

In case you hadn’t heard, the Welsh, Carson, Anderson & Stowe private equity firm was featured in several deal announcements last week. The largest deal, at $1.06 billion, was for Concentra Inc., a subsidiary of Humana Inc. (NYSE: HUM), which operates urgent care, occupational medicine, physical therapy and other programs. For the transaction, Welsh, Carson formed a joint venture with Select Medical Corporation (NYSE: SEM), which operates specialty hospitals and outpatient rehab clinics. Then there was the sale of a majority stake in its portfolio company, United Surgical Partners Inc. Tenet Healthcare Corporation (NYSE: THC) paid $425 million for a 50.1% interest, and will acquire the... Read More »

March Healthcare M&A Madness

March isn’t quite over as we write this, and neither is the madness—which won’t stop us from posting the biggest deals of the month. As of Friday, March 27, $34.4 billion has been committed to finance about 105 transactions. Of course, $21 billion of that comes from the AbbVie (NYSE: ABBV) acquisition of Pharmacyclics (NASDAQ: PCYC). Next week, preliminary Q1:15 results! Read More »

Fred’s Inc. Buys EntrustRx

Specialty pharmaceutical companies are still in strong demand, and so are specialty pharmacies. Three deals in the first quarter of 2015 have been announced, the most recent being last week’s $66 million acquisition of Reeves-Sain Drug Store, Inc., a private specialty and retail pharmacy company, by Fred’s Inc. (NASDAQ: FRED). Fred’s sells general merchandise through 661 retail discount stores and full-service pharmacies in the southeastern United States. This transaction nets it a single Reeves-Sain retail pharmacy in Murfreesboro, Tennessee, and Columbus, Mississippi. Read More »

Fortis Sells its Singapore Surgical Hospital

Fortis Healthcare International Pte Ltd, a subsidiary of Fortis Healthcare Ltd (BSE: FORTIS), sold its Fortis Surgical Hospital in Singapore to Beijing-based Concord Medical Services Holdings Limited (NYSE: CCM). The 31-bed hospital sold for $39.8 million, or $1.28 million per bed. Concord plans to rename the facility the Singapore Concord Cancer Hospital, and to add more medical specialties, such as oncology, cardiology, respiratory, dermatology, renal medicine and more. Read More »